| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |